Depressive Symptoms and Subjective Stress in the Course of the Menstrual Cycle - an Ambulatory Assessment Study. (DepCy)

Freie Universität Berlin

Status: Completed

Conditions: Major Depressive Episode

Study type: Observational

Funder types: Other

Identifiers

NCT04086316

CycleDepression

Details and patient eligibility

About

Background:

Major changes in female sex hormone concentrations influence the development of depressive symptoms in women. This hypothesis has been thoroughly investigated with regard to the menopause, the postpartal phase and also premenstrual dysphoric disorder. However, much less is known regarding the impact of female sex hormone fluctuations on depression during the regular menstrual cycle. There are indications that during the luteal phase, women might be more vulnerable to the development of depressive symptoms, while during the follicular phase and at ovulation, hormone concentrations might present a protective factor against depressive symptomatology. Subjective stress could mediate the relationship between depressive symptom development and the menstrual cycle phases. The complex interaction between sex hormones and psychological symptoms in the course of menstrual cycle phases is still understudied.

Method:

74 women (37 with and 37 without current depressive episode), will take part in a smartphone-based ambulatory assessment. Women will provide daily ratings of depressive symptoms and perceived stress for a period of one menstrual cycle (approx. 26-30 days). Three menstrual cycle phases will be assessed - the follicular phase, ovulation and the luteal phase. An ambulatory assessment will be used for these daily assessments. To assess the menstrual cycle phase participants will use ovulation tests on five days in the late follicular phase.

The following research questions will be investigated:

Research question 1: Do depressive symptoms (number and severity) change in the course of the menstrual cycle within the two groups? Research question 2: Which depressive symptoms are particularly sensitive to changes in the course of the menstrual cycle phases? Research question 3: Does the subjective stress change in the course of the menstrual cycle within the two groups? Research question 4: Are there differences between depressive and healthy women in terms of changes in depressive symptoms and subjective stress experience?

Implications:

The aim of the study is to investigate women-specific psychobiological factors influencing depression. Therefore, fluctuations in depressive symptoms and subjective stress experience will be investigated as a function of the respective menstrual cycle phases. The identification of cycle phases associated with increased or reduced vulnerability to depressive symptoms will support the development of women-specific prevention and treatment programs.

Enrollment: 77 patients

Sex: Female

Ages: 18 to 45 years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

For participants with major depressive episode:

Inclusion criteria:

• female sex
• current diagnosis of a major depression episode
• minimum age of 18 years
• regular menstrual cycle.

Exclusion criteria:

• Pregnancy less than one year ago;
• women who are breastfeeding;
• bipolar disorder;
• acute suicidal tendencies;
• schizophrenic disorders (F20-29);
• substance use disorders
• psychotropic drugs in the last six months;
• chronic somatic diseases.

For participants without major depressive episode:

Inclusion criteria:

• female sex;
• minimum age of 18 years;
• regular menstrual cycle.

Exclusion criteria:

• current or lifetime mental disorder;
• pregnancy less than one year ago;
• women who are breastfeeding;
• psychotropic drugs in the last six months;
• chronic somatic diseases.

Trial design

77 participants in 2 patient groups

Depression Group

Description:

Naturally cycling women with a major depressive episode, assessed by Structured Clinical Interview for DSM-5 (SCID Clinical Version)

Healthy Group

Description:

Naturally cycling women without a major depressive episode, assessed by Structured Clinical Interview for DSM-5 (SCID Clinical Version)